Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Ipsen will acquire Kartos for up to $1.75 billion

Ipsen will acquire Kartos for up to $1.75 billion

格隆汇格隆汇2026/06/29 05:24
Show original
Golden Ten Data, June 29 — Ipsen announced that it has agreed to acquire Kartos Therapeutics in a deal valued at up to $1.75 billion, aiming to strengthen the French pharmaceutical company's pipeline of cancer drugs. According to Ipsen, under the agreement, the company will make an upfront payment of $450 million to acquire Kartos, with up to an additional $1.3 billion contingent on regulatory and sales milestones. Ipsen stated that the acquisition of the unlisted Kartos will bring navtemadlin into its late-stage oncology pipeline. This candidate drug is used for the treatment of myelofibrosis, a rare blood cancer, and is currently in late-stage clinical trials. The company added that the transaction is expected to be completed by the end of the third quarter, subject to customary closing conditions.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The new Roadster, postponed for nine years, finally has a release date! Morningstar maintains Tesla (TSLA.US) target price at $450: Supercars are not the valuation logic, FSD, Robotaxi, and Optimus are.

Tesla has officially announced that the new generation Roadster will be unveiled on October 1. However, institutions generally believe that this is primarily a branding campaign and will have minimal impact on the company's valuation.

智通财经2026/09/21 08:51